{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:46:54Z","timestamp":1758991614753,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1038\/s41433-020-01174-6","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T12:03:09Z","timestamp":1600084989000},"page":"1922-1929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An objective method of diagnosing hydroxychloroquine maculopathy"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-4253","authenticated-orcid":false,"given":"Hani","family":"Hasan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-4305","authenticated-orcid":false,"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"1174_CR1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/eye.2016.298","volume":"4","author":"IH Yusuf","year":"2017","unstructured":"Yusuf IH, Sharma S, Luqmani R, Downes SM. Hydroxychloroquine retinopathy. Eye. 2017;4:828\u201345.","journal-title":"Eye."},{"key":"1174_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13075-018-1634-8","volume":"20","author":"AM Jorge","year":"2018","unstructured":"Jorge AM, Melles RB, Zhang Y, Lu N, Rai SK, Young LH, et al. Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines. Arthritis Res Ther. 2018;20:133\u201340.","journal-title":"Arthritis Res Ther."},{"key":"1174_CR3","doi-asserted-by":"crossref","unstructured":"Browning DJ. Hydroxychloroquine and chloroquine retinopathy. 1st ed. York, UK: Springer; 2014.","DOI":"10.1007\/978-1-4939-0597-3_1"},{"key":"1174_CR4","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2147\/OPTH.S163451","volume":"12","author":"DJ Browning","year":"2018","unstructured":"Browning DJ, Lee C. Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines. Clin Ophthalmol. 2018;12:811\u20138.","journal-title":"Clin Ophthalmol."},{"key":"1174_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","volume":"122","author":"RB Melles","year":"2015","unstructured":"Melles RB, Marmor MF. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity. Ophthalmology 2015;122:110\u20136.","journal-title":"Ophthalmology"},{"key":"1174_CR6","unstructured":"Lotery A, Yusuf I, Foot B, Bishop P, Burdon M, Watson S, et al. Hydroxychloroquine and chloroquine retinopathy: recommendations on screening. London: The Royal College of Ophthalmologists; 2018."},{"key":"1174_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/eye.2011.245","volume":"25","author":"C Anderson","year":"2011","unstructured":"Anderson C, Blaha GR, Marx JL. Humphrey visual field findings in hydroxychloroquine toxicity. Eye. 2011;25:1535\u201345.","journal-title":"Eye."},{"key":"1174_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2147\/OPTH.S14257","volume":"4","author":"E Chen","year":"2010","unstructured":"Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY, et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the \u201cflying saucer\u201d sign). Clin Ophthalmol. 2010;4:1151\u20138.","journal-title":"Clin Ophthalmol."},{"key":"1174_CR9","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1167\/iovs.17-22668","volume":"59","author":"AM Allahdina","year":"2018","unstructured":"Allahdina AM, Stetson PF, Vitale S, Wong WT, Chew EY, Ferris FL, et al. Optical coherence tomography minimum intensity as an objective measure for the detection of hydroxychloroquine toxicity. Invest Ophthalmol Vis Sci. 2018;59:1953\u201363.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"1174_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajo.2017.09.025","volume":"9","author":"SJ Ahn","year":"2017","unstructured":"Ahn SJ, Joung J, Lim HW, Lee BR. Optical coherence tomography protocols for screening of hydroxychloroquine retinopathy in asian patients. Am J Ophthalmol. 2017;9:11\u201318.","journal-title":"Am J Ophthalmol."},{"key":"1174_CR11","unstructured":"Kolb H, Fernandez E, Nelson R. Webvision: the organization of the retina and visual system [Internet]. Salt Lake City, UT: University of Utah Health Sciences Center; 1995."},{"key":"1174_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/cc3045","volume":"9","author":"V Bewick","year":"2005","unstructured":"Bewick V, Cheek L, Ball J. Statistics review 14: logistic regression. Crit Care. 2005;9:112\u20138.","journal-title":"Crit Care."},{"key":"1174_CR13","first-page":"1","volume":"0","author":"M Iftikhar","year":"2018","unstructured":"Iftikhar M, Kaur R, Nefalar A, Usmani B, Kherani S, Rashid I, et al. Microperimetry as a screening test for hydroxychloroquine retinopathy The Hard-Risk-1 Study. J Retinal Vitreous Dis. 2018;0:1\u20137.","journal-title":"J Retinal Vitreous Dis."},{"key":"1174_CR14","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/bjd.15567","volume":"176","author":"WR Tucker","year":"2017","unstructured":"Tucker WR, Galloway J, Walsh S. The gathering storm: hydroxychloroquine retinopathy screening in the U.K. Br J Dermatol. 2017;176:1420\u20131.","journal-title":"Br J Dermatol."},{"key":"1174_CR15","first-page":"41","volume":"5","author":"G Espandar","year":"2016","unstructured":"Espandar G, Moghimi J, Ghorbani R, Pourazizi M, Seiri MA, et al. Retinal toxicity in patients treated with hydroxychloroquine: a cross-sectional study. Med Hypothesis Disco Innov Ophthalmol. 2016;5:41\u201346.","journal-title":"Med Hypothesis Disco Innov Ophthalmol."},{"key":"1174_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1055\/s-0042-102615","volume":"233","author":"KC Iselin","year":"2016","unstructured":"Iselin KC, Marti P, Pless M. Hydroxychloroquine-induced retinal toxicity. Klin Monatsbl Augenheilkd. 2016;233:514\u20136.","journal-title":"Klin Monatsbl Augenheilkd."},{"key":"1174_CR17","unstructured":"Brownlee J. Logistic regression for machine learning. Machine Learning Mastery Pty. Ltd., Australia. 2016. https:\/\/machinelearningmastery.com\/logistic-regression-for-machine-learning\/. Accessed 01 April 2016."},{"key":"1174_CR18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/aos.13276","volume":"14","author":"F Babeau","year":"2017","unstructured":"Babeau F, Busetto T, Hamel C, Villain M, Daien V. Adaptive optics: a tool for screening hydroxychloroquine-induced maculopathy? Acta Ophthalmol. 2017;14:424\u20135.","journal-title":"Acta Ophthalmol."},{"key":"1174_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40942-016-0042-y","volume":"2","author":"DR Lally","year":"2016","unstructured":"Lally DR, Heier JS, Baumal C, Witkin AJ, Maler S, Shah CP, et al. Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation. Int J Retin Vitr. 2016;2:1\u201311.","journal-title":"Int J Retin Vitr."},{"key":"1174_CR20","first-page":"693","volume":"6","author":"A Khaleel","year":"2018","unstructured":"Khaleel A. Risk of ophthalmologic complications as a result of hydroxychloroquine therapy. Ann Rheum Dis. 2018;6:693\u20134.","journal-title":"Ann Rheum Dis."},{"key":"1174_CR21","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","volume":"123","author":"M Marmor","year":"2016","unstructured":"Marmor M, Kellner U, Lai T, Melles R, Mieler W. Recommendations on screenig for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016;123:1386\u201394.","journal-title":"Ophthalmology"},{"key":"1174_CR22","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00417-018-4103-9","volume":"256","author":"G Ruberto","year":"2018","unstructured":"Ruberto G, Bruttini C, Tinelli C, Cavagna L, Bianchi A, Milano G. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study. Graefes Arch Clin Exp Ophthalmol. 2018;256:2201\u201310.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"1174_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/archopht.125.6.775","volume":"125","author":"JA Rodriguez-Padilla","year":"2007","unstructured":"Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E, et al. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol. 2007;125:775\u201380.","journal-title":"Arch Ophthalmol."},{"key":"1174_CR24","first-page":"33","volume":"76","author":"M Hansen","year":"2011","unstructured":"Hansen M, Schuman S. Hydroxychloroquine-induced retinal toxicity. EyeNet Mag. 2011;76:33\u201335.","journal-title":"EyeNet Mag."},{"key":"1174_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jaad.2017.07.061","volume":"7","author":"GP Smith","year":"2017","unstructured":"Smith GP. High-risk category for early annual ophthalmology screening of patients receiving hydroxychloroquine. J Am Acad Dermatol. 2017;7:171.","journal-title":"J Am Acad Dermatol."},{"key":"1174_CR26","first-page":"280","volume":"17","author":"EM Stern","year":"2017","unstructured":"Stern EM, Johnson JS, Mazzulla DA. Highly accelerated onset of hydroxychloroquine macular retinopathy. Ochsner J. 2017;17:280\u20133.","journal-title":"Ochsner J."},{"key":"1174_CR27","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1038\/s41433-019-0418-y","volume":"33","author":"FH Zaidi","year":"2019","unstructured":"Zaidi FH, Rennie CA, Drinkwater AK, Sahu D, Akyol E, Lotery AJ. How to set up a hydroxychloroquine retinopathy screening service. Eye. 2019;33:1679\u201382.","journal-title":"Eye."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01174-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01174-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T23:30:09Z","timestamp":1631575809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-020-01174-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1174"],"URL":"https:\/\/doi.org\/10.1038\/s41433-020-01174-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"type":"print","value":"0950-222X"},{"type":"electronic","value":"1476-5454"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"23 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}